Roche diagnostics corp:1106277 [16-035258]

Ended Awarded Last action

Contract number
HHSN26100033
Awardee
Awarding agency
Obligated
$26,365

Award facts

Opportunity
Contract value 100% obligated
$26,365.32 Current and potential, with all options
Completion date
Current and potential, with all options
Set-aside
No set-aside
Competition
Not Competed under SAP Simplified Acquisition
Pricing
Firm Fixed Price
Place of performance
Bethesda, MD 20892, USA

Award details come from SAM.gov/FPDS.

Transactions

Action Obligated Date
Funding Only Action P00001 -$415
Original award $26,780

About this award

The National Cancer Institute issued a $26,365.32 delivery order to Roche Diagnostics Corporation on April 14, 2016, for in vitro diagnostic products and laboratory instruments.

Place of performance is Bethesda, MD. The order was firm fixed price with no set-aside designation and an ultimate completion date of April 14, 2016.

Quick answers

Who was awarded contract HHSN26100033?

HHSN26100033 was awarded to Roche Diagnostics Corporation by National Cancer Institute (National Institutes of Health) on April 14, 2016.

How much is contract HHSN26100033 worth?

The government has obligated $26,365 on HHSN26100033.

Is contract HHSN26100033 an order under another contract?

Yes. HHSN26100033 is a delivery order under HHSN261201500001I, an indefinite delivery contract.

Was contract HHSN26100033 competed?

The extent of competition for HHSN26100033 was not competed under sap.

On GovTribe

See this award's full record

  • Every transaction and funding action
  • The awardee's other awards and teaming partners
  • Similar awards and recompete opportunities
  • Ask GovTribe AI about this award